Danazol treatment of advanced prostate cancer: Clinical and hormonal effects
Danazol treatment of 19 advanced prostate cancer patients showed no objective remissions but stable disease in 15.8% of cases, alongside significant tumor flare reactions and potential treatment-related mortality.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Danazol effects on gowadotrop in basal levels and pituitary responsiveness to lh-rn in immature male rats via openalex
- Danazol increasingly used. via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol treatment of advanced breast cancer. via openalex
- Effects of Danazol on Pituitary Gonadotrophins in Post‐Menopausal Women via openalex
- Further studies on danazol interference in testosterone radioimmunoassays. via openalex
- Further studies on danazol interference in testosterone radioimmunoassays. via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- Pituitary Gonadotropin Responsiveness with Danazol via openalex
- The Effect of Danazol on Anterior Pituitary Function via openalex
- W6643992471 via openalex
- doi:10.1002/pros.2990050405 via openalex
- doi:10.1095/biolreprod10.4.438 via openalex
- doi:10.1016/s0015-0282(16)43953-1 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-10T18:12:33.072680+00:00